The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy. (Q34373936)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy. |
scientific article |
Statements
The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy (English)
Ramón M Pérez Carrión
Luis Manso
Carmen Crespo
Cesar Mendiola
Rocío López-Vacas
Julia Berges-Soria
Isabel Álvarez López
Mireia Margeli
Juan L Bayo Calero
Xavier González Farre
Ana Santaballa
Ruth Afonso
Juan Lao
Gustavo Catalán
José V Álvarez Gallego
José Miramón López
Francisco J Salvador Bofill
Manuel Ruiz Borrego
Enrique Espinosa
Juan A Fresno Vara
20 October 2014
20 October 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference